Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

January 14, 2025
Otsuka Pharmaceutical

MIREVO, the first neuropsychological testing program in Japan to support dementia treatment, now available
January 10, 2025
Otsuka Pharmaceutical

Otsuka Announces FDA Plans to Host an Advisory Committee Meeting to Discuss the sNDA for Brexpiprazole in Combination with Sertraline for the Treatment of Adults with Post-Traumatic Stress Disorder (PTSD)
January 6, 2025
Otsuka Pharmaceutical

European Medicines Agency Commences Review of Donidalorsen in Hereditary Angioedema
December 23, 2024
Otsuka Foods

Otsuka Foods to Revise Prices of Some Products New Prices to Take Effect with Deliveries as of March 1, 2025
December 19, 2024
Otsuka Pharmaceutical

Detailed Findings in JAMA Psychiatry Show Otsuka and Lundbeck’s Phase 3 Trial of Brexpiprazole in Combination with Sertraline Significantly Improved Symptoms of Post-Traumatic Stress Disorder (PTSD) in Adults
December 12, 2024
Otsuka Pharmaceutical

Otsuka and Jolly Good initiate the sale of FACEDUO Dementia Care Support VR
December 5, 2024
Otsuka Pharmaceutical

Otsuka Expanding Use of Environmentally Friendly, Reusable Temperature-Controlled Containers
November 27, 2024
Otsuka Pharmaceutical

Otsuka Pharmaceutical Launches POCARI SWEAT Basketball Dream Project to Promote Sports and International Exchanges
November 26, 2024
Otsuka Pharmaceutical

Otsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia
November 22, 2024
Otsuka Pharmaceutical

Otsuka Obtains Exclusive Global Licensing Rights from Ionis to Ulefnersen, a Potential Treatment for Amyotrophic Lateral Sclerosis Caused by Mutations in the Fused in Sarcoma Gene (FUS-ALS)
November 20, 2024
Otsuka Pharmaceutical

Otsuka launches Lupkynis in Japan
November 19, 2024
Otsuka Pharmaceutical

Otsuka Provides Update on Sibeprenlimab, an Investigational Monoclonal Antibody for the Treatment of IgA Nephropathy in Adults
November 13, 2024
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory and ICU Medical Announce the Establishment of Joint Venture
November 5, 2024
Taiho Pharmaceutical

Taiho Innovations, LLC. Selected as a Registered Venture Capital in AMED’s Strengthening Program for Pharmaceutical Startup Ecosystem
October 31, 2024
Otsuka HoldingsOtsuka Pharmaceutical

Otsuka Announces Personnel Changes
October 29, 2024
Otsuka HoldingsOtsuka Pharmaceutical Factory

Supply of Renewable Energy to Business Partners -Towards Achieving Carbon Neutrality Throughout Our Supply Chain-
October 22, 2024
Otsuka Pharmaceutical

Otsuka Announces Positive Interim Results from the Phase 3 Trial of Sibeprenlimab for the Treatment of Immunoglobulin A Nephropathy in Adults
September 30, 2024
Otsuka Holdings

Otsuka Group Establishes Solar Power Generation Facility in Naka, Tokushima The New Facility Advances the Company’s Carbon Neutrality Initiative
September 30, 2024
Otsuka Pharmaceutical Factory

EN Otsuka Pharmaceutical Co., Ltd. obtains marketing approval of "ENOSOLID Semi Solid for Enteral Use"
September 27, 2024
Otsuka Pharmaceutical

Heartful Kawauchi Received Japan Organization for Employment of the Elderly, Persons with Disabilities and Job Seekers President’s Award
September 25, 2024
Otsuka Pharmaceutical

Otsuka Pharmaceutical Advancing Women's Health Business Bonafide Health Launched “Thermella”, a Plant-derived Supplement to Support Menopausal Women in the U.S.
September 24, 2024
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory obtains marketing approval of "KIDPAREN Injection," the amino acid, glucose, electrolyte, fat, and multivitamin injection for high calorie parenteral nutrition of patients with chronic kidney disease
September 24, 2024
Otsuka Pharmaceutical

Otsuka Receives Approval in Japan for Lupkynis as a Treatment for Lupus Nephritis
September 24, 2024
Otsuka Pharmaceutical

Otsuka Obtains Additional Indication for Rexulti® in Japan as an Adjunctive Treatment for Agitation Associated with Dementia due to Alzheimer's Disease
September 24, 2024
Taiho Pharmaceutical

Taiho Pharmaceutical and Haihe Biopharma Announce the Launch of MET Inhibitor HAIYITAN® Tablets 50mg in Japan
September 24, 2024
Otsuka Pharmaceutical

Otsuka Pharmaceutical Completes Acquisition of Jnana Therapeutics Inc.
September 19, 2024
Otsuka Pharmaceutical

Otsuka to Participate in the Orange Innovation Project, Promoted by Japan’s Ministry of Economy, Trade and Industry
September 17, 2024
Otsuka Pharmaceutical

Otsuka Pharmaceutical Launches Corporate Health Support Program "fitbiz" Supporting Employees in Building and Maintaining Healthy Habits
September 13, 2024
Otsuka Pharmaceutical

Otsuka Pharmaceutical signs global supporter agreement with World Athletics Sponsorship will cover the World Athletics Championships Tokyo 25 　POCARI SWEAT will support the event with the key message “Believe In Your Potential.”
September 13, 2024
Otsuka Holdings

Notice regarding Issuance Conditions of Green Bonds

Otsuka Group News

First 30 results